Digestive Diseases and Sciences

, Volume 50, Issue 3, pp 509–513 | Cite as

Multifocal Gastric Carcinoid Tumor in a Patient with Pernicious Anemia Receiving Lansoprazole

  • Tan Attila
  • Raj Santharam
  • Dennis Blom
  • Richard Komorowski
  • Timothy R. KochEmail author
Case Report


carcinoid tumor stomach proton pump inhibitor gastrin. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 79(4):813–829, 1997CrossRefPubMedGoogle Scholar
  2. 2.
    Thompson GB, van Heerden JA, Martin JK Jr, Schutt AJ, Ilstrup DM, Carney JA: Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 98:1054–1063, 1985PubMedGoogle Scholar
  3. 3.
    Carney JA, Go VLW, Fairbanks VF, Moore SB, Alport EC, Nora FE: The syndrome of gastric carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 99:761–766, 1983PubMedGoogle Scholar
  4. 4.
    Freston JW, Borch K, Brand SJ, Carlsson E, Creutzfeldt W, Hakanson R, Olbe L, Solcia E, Walsh JH, Wolfe MM: Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci 40(Suppl 2):50S–62S, 1995PubMedGoogle Scholar
  5. 5.
    Havu N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(Suppl 1):42–55, 1986PubMedGoogle Scholar
  6. 6.
    Solcia E, Rindi G, Havu N, Elm G: Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol Suppl 166:129–137, 1989PubMedGoogle Scholar
  7. 7.
    Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimur M, Ogawa M: Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 43:253–257, 1998PubMedGoogle Scholar
  8. 8.
    Modlin IM, Lye KD, Kidd M: A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 99:23–32, 2004PubMedGoogle Scholar
  9. 9.
    Hirschowitz BI, Griffith J, Pellegrin D, Cummings OV: Rapid regression of enterochromaffin-like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102:1409–1418, 1992PubMedGoogle Scholar
  10. 10.
    Bashir S, Gibril F, Ojeaburu JV, Asgharian B, Entsuah LK, Ferraro G, Crafa P, Bordi C, Jensen RT: Prospective study of the ability of histamine, serotonin, or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Aliment Pharmacol Ther 16:1367–1382, 2002PubMedGoogle Scholar
  11. 11.
    Freston JW: Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51(Suppl 1):102–114, 1992CrossRefPubMedGoogle Scholar
  12. 12.
    De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF: Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 26:82–88, 2003PubMedGoogle Scholar
  13. 13.
    Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H: The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anemia. A prospective follow-up study. Scand J Gastroenterol 33:88–92, 1998PubMedGoogle Scholar
  14. 14.
    Bresky G, Mata A, Llach J, Ginis MA, Pellisi M, Soria MT, Fernandez-Esparrach G, Mondelo F, Bordas JM: Endoscopic findings in a biennial follow-up program in patients with pernicious anemia. Hepatogastroenterology 50:2264–2266, 2003PubMedGoogle Scholar
  15. 15.
    Modlin IM, Lye KD, Kidd M: Carcinoid tumors of the stomach. Surg Oncol 12:153–172, 2003CrossRefPubMedGoogle Scholar
  16. 16.
    Heah SM, Eu KW, Ooi BS, et al.: Tumor size is irrelevant in predicting malignant potential of carcinoid tumors of the rectum. Tech Coloproctology 5:73–77, 2001Google Scholar
  17. 17.
    Debelenko LV, Emmert-Buck MR, Zhuang Z, et al.: The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type H gastric carcinoids. Gastroenterology 113:773–781, 1997PubMedGoogle Scholar
  18. 18.
    Waldum HL, Sandvik AK, Idle JR: Gastrin is the most important factor in ECL tumorigenesis. Gastroenterology 114:1113–1114, 1998PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Tan Attila
    • 1
  • Raj Santharam
    • 1
  • Dennis Blom
    • 2
  • Richard Komorowski
    • 3
  • Timothy R. Koch
    • 1
    • 4
    Email author
  1. 1.Division of Gastroenterology & Hepatology, Department of MedicineMedical College of WisconsinMilwaukeeUSA
  2. 2.Department of SurgeryMedical College of WisconsinMilwaukeeUSA
  3. 3.Department of PathologyMedical College of WisconsinMilwaukeeUSA
  4. 4.Division of Gastroenterology & HepatologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations